vs
Side-by-side financial comparison of CG Oncology, Inc. (CGON) and INTRUSION INC (INTZ). Click either name above to swap in a different company.
CG Oncology, Inc. is the larger business by last-quarter revenue ($2.3M vs $1.5M, roughly 1.6× INTRUSION INC). INTRUSION INC runs the higher net margin — -190.7% vs -1779.0%, a 1588.3% gap on every dollar of revenue. On growth, CG Oncology, Inc. posted the faster year-over-year revenue change (409.2% vs -11.6%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-36.2M).
CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
CGON vs INTZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3M | $1.5M |
| Net Profit | $-41.3M | $-2.8M |
| Gross Margin | — | 74.3% |
| Operating Margin | -2097.3% | -192.4% |
| Net Margin | -1779.0% | -190.7% |
| Revenue YoY | 409.2% | -11.6% |
| Net Profit YoY | -29.9% | -44.4% |
| EPS (diluted) | $-0.52 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.3M | $1.5M | ||
| Q3 25 | $1.7M | $2.0M | ||
| Q2 25 | $0 | $1.9M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | $456.0K | $1.7M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | $529.0K | $1.1M |
| Q4 25 | $-41.3M | $-2.8M | ||
| Q3 25 | $-43.8M | $-2.1M | ||
| Q2 25 | $-41.4M | $-2.0M | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | $-31.8M | $-2.0M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-2.1M | ||
| Q1 24 | $-16.9M | $-1.7M |
| Q4 25 | — | 74.3% | ||
| Q3 25 | — | 76.6% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 75.7% | ||
| Q4 24 | — | 74.9% | ||
| Q3 24 | — | 77.1% | ||
| Q2 24 | — | 76.0% | ||
| Q1 24 | — | 80.0% |
| Q4 25 | -2097.3% | -192.4% | ||
| Q3 25 | -3069.0% | -108.6% | ||
| Q2 25 | — | -111.4% | ||
| Q1 25 | — | -117.9% | ||
| Q4 24 | -8344.1% | -113.5% | ||
| Q3 24 | — | -135.5% | ||
| Q2 24 | — | -139.2% | ||
| Q1 24 | -4247.4% | -218.6% |
| Q4 25 | -1779.0% | -190.7% | ||
| Q3 25 | -2629.5% | -106.5% | ||
| Q2 25 | — | -109.0% | ||
| Q1 25 | — | -118.2% | ||
| Q4 24 | -6973.7% | -116.8% | ||
| Q3 24 | — | -136.3% | ||
| Q2 24 | — | -141.6% | ||
| Q1 24 | -3200.8% | -151.7% |
| Q4 25 | $-0.52 | $-0.15 | ||
| Q3 25 | $-0.57 | $-0.10 | ||
| Q2 25 | $-0.54 | $-0.10 | ||
| Q1 25 | — | $-0.11 | ||
| Q4 24 | $-0.47 | $0.19 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $-0.53 | ||
| Q1 24 | $-0.36 | $-0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $742.2M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $752.6M | $7.3M |
| Total Assets | $791.6M | $10.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $742.2M | $3.6M | ||
| Q3 25 | $680.3M | $4.5M | ||
| Q2 25 | $661.1M | $8.4M | ||
| Q1 25 | — | $10.7M | ||
| Q4 24 | $742.0M | $4.9M | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | $566.5M | $122.0K |
| Q4 25 | $752.6M | $7.3M | ||
| Q3 25 | $687.6M | $9.8M | ||
| Q2 25 | $670.4M | $11.6M | ||
| Q1 25 | — | $13.4M | ||
| Q4 24 | $733.4M | $6.3M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | $568.9M | $-1.2M |
| Q4 25 | $791.6M | $10.4M | ||
| Q3 25 | $729.9M | $13.7M | ||
| Q2 25 | $701.4M | $16.4M | ||
| Q1 25 | — | $18.0M | ||
| Q4 24 | $754.8M | $11.5M | ||
| Q3 24 | — | $7.4M | ||
| Q2 24 | — | $7.5M | ||
| Q1 24 | $579.1M | $5.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-36.2M | $-531.0K |
| Free Cash FlowOCF − Capex | $-36.2M | $-549.0K |
| FCF MarginFCF / Revenue | -1560.0% | -37.1% |
| Capex IntensityCapex / Revenue | 0.3% | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-124.1M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-36.2M | $-531.0K | ||
| Q3 25 | $-38.9M | $-3.0M | ||
| Q2 25 | $-28.0M | $-1.6M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | $-20.7M | $-178.0K | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-2.9M | ||
| Q1 24 | $-26.0M | $-1.1M |
| Q4 25 | $-36.2M | $-549.0K | ||
| Q3 25 | $-39.0M | $-3.0M | ||
| Q2 25 | $-28.0M | $-1.9M | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | $-20.9M | $-645.0K | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-3.0M | ||
| Q1 24 | $-26.0M | $-1.2M |
| Q4 25 | -1560.0% | -37.1% | ||
| Q3 25 | -2340.4% | -153.2% | ||
| Q2 25 | — | -101.1% | ||
| Q1 25 | — | -117.3% | ||
| Q4 24 | -4577.0% | -38.5% | ||
| Q3 24 | — | -140.4% | ||
| Q2 24 | — | -202.3% | ||
| Q1 24 | -4919.5% | -104.2% |
| Q4 25 | 0.3% | 1.2% | ||
| Q3 25 | 5.8% | 1.7% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 22.1% | ||
| Q4 24 | 45.8% | 27.9% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | 2.3% | 5.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
